Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2001
03/21/2001CN1063334C Nutrition liquor contg. silk moth essence
03/20/2001US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same
03/20/2001US6204280 Oxazolidinone derivative, anticoagulant
03/20/2001US6204047 Growth differentiation factor-10
03/20/2001US6204015 Aminopeptidase from staphylococcus aureus
03/20/2001CA2158399C Novel pharmaceutical product
03/15/2001WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells
03/15/2001WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
03/15/2001WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
03/15/2001WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies
03/15/2001WO2001018040A2 Use of leptin in inhibition of endothelial cell proliferation
03/15/2001WO2001018027A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
03/15/2001WO2001018026A1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds
03/15/2001WO2001018025A2 17alpha propynyl 11-aryl steroids
03/15/2001WO2001018024A1 Antisense modulation of x-linked inhibitor of apoptosis expression
03/15/2001WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies
03/15/2001WO2001018004A2 PYRAZOLO[4,3-d]PYRIMIDINES
03/15/2001WO2001017989A2 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists
03/15/2001WO2001017988A1 Novel chalcones
03/15/2001WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
03/15/2001WO2001017985A1 Novel derivatives of flavones, xanthones and coumarins
03/15/2001WO2001017984A1 Chalcone coumarins
03/15/2001WO2001017963A2 Aminoalkoxy carbazoles and their use as 5-ht ligands
03/15/2001WO2001017521A1 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
03/15/2001WO2001017512A2 Combination preparation for initiation of oestrus
03/15/2001WO2000061604A3 Pharmaceutical compounds
03/15/2001WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
03/15/2001WO1999062545A3 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS
03/15/2001DE19943815A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen
03/15/2001DE19942474A1 Pyrazolo[4,3-d]pyrimidine Pyrazolo [4,3-d] pyrimidines
03/15/2001DE19937304A1 Verwendung von CGRP-Antagonisten und CGRP-Release-Hemmern zur Bekämpfung menopausaler Hitzewallungen Use of CGRP antagonists and CGRP release inhibitors to combat menopausal hot flashes
03/15/2001CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies
03/15/2001CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies
03/15/2001CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
03/15/2001CA2384456A1 Antisense modulation of x-linked inhibitor of apoptosis expression
03/15/2001CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
03/15/2001CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
03/15/2001CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells
03/15/2001CA2382130A1 Novel chalcones
03/15/2001CA2382112A1 Chalcone coumarins
03/15/2001CA2380763A1 Aminoalkoxy carbazoles for the treatment of cns diseases
03/14/2001EP1082962A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZO C ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-$g(k)B
03/14/2001EP1082433A1 Interleukins-21 and 22
03/14/2001EP1082338A1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
03/14/2001EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/14/2001EP1082129A1 Method for the treatment of fertility disorders
03/14/2001EP1082112A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
03/14/2001CN1287123A Steroid and its preparation method, medicine composition and application
03/14/2001CN1286989A Suppository for treating cervical erosion and vaginitis
03/14/2001CN1286985A Externally applied Chinese medicine
03/14/2001CN1063087C Medicine for treating menalgia and its preparing method
03/14/2001CN1063085C Health food and its producing method
03/14/2001CN1063084C Puhuang pills
03/14/2001CN1063068C Medicine for dispelling colds and warming kidney
03/14/2001CN1063067C Capsule for curing mammary gland hyperplasis
03/13/2001US6201132 Inhibitors of membrane-bound serine protease; aminoacyl compounds
03/13/2001US6201025 For treatment of central nervous system disorders
03/13/2001US6201004 Dioxino derivatives and their use as therapeutic agents
03/13/2001US6200983 For treating erectile dysfunction in psychogenic male patients; time-release agents
03/13/2001US6200957 Useful for treatment of variety of sex-hormone related and other conditions in both men and women
03/13/2001US6200774 Compounds
03/13/2001US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein
03/13/2001US6200571 Administering sturgeon fish roe and a member selected from the group consisting of ginkgo biloba, ginkgo biloba leaf extract, yohimbine, and yohimbine hydrochloride
03/13/2001CA2033937C Hemihydrate
03/13/2001CA1341204C Analogues of igf-1 and igf-2
03/08/2001WO2001016330A2 Prevention of affections associated with porcine circovirus-2
03/08/2001WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor
03/08/2001WO2001016293A2 Dna encoding the human serine protease t
03/08/2001WO2001016289A2 Zymogen activation system
03/08/2001WO2001016288A2 Dna encoding the human serine protease c-e
03/08/2001WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
03/08/2001WO2001016139A1 Androgen receptor modulator compounds and methods
03/08/2001WO2001016134A1 Selective antagonists of a2b adenosine receptors
03/08/2001WO2001016133A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
03/08/2001WO2001016123A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation
03/08/2001WO2001016122A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
03/08/2001WO2001016121A1 Heterocyclic compounds and methods of use thereof
03/08/2001WO2001016108A2 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/08/2001WO2001015730A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES
03/08/2001WO2001015718A1 Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof
03/08/2001WO2001015707A1 Uses of diterpenoid triepoxides as an anti-proliferative agent
03/08/2001WO2001015701A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
03/08/2001WO2001015679A2 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders
03/08/2001WO2001015668A1 Controlled release pellet formulation
03/08/2001WO2001015664A2 Coformulation methods and their products
03/08/2001WO2001015554A1 Metal-containing compositions, preparations and uses
03/08/2001WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
03/08/2001WO2000054762A3 Use of cross linked polysaccharides for the inhibition of angiogenesis
03/08/2001WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
03/08/2001WO1999063930A8 Novel angiotensin receptor modulators and their uses
03/08/2001CA2387291A1 Dna encoding the human serine protease t
03/08/2001CA2384435A1 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/08/2001CA2384194A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation
03/08/2001CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor
03/08/2001CA2383877A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
03/08/2001CA2383367A1 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
03/08/2001CA2383347A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
03/08/2001CA2383077A1 Androgen receptor modulator compounds and methods
03/08/2001CA2382961A1 Zymogen activation system